For Localized NSCLC, Vaccine-Based Immunotherapy Does Not Affect Survival – Journal of Clinical Pathways
|
For Localized NSCLC, Vaccine-Based Immunotherapy Does Not Affect Survival
Journal of Clinical Pathways Vaccine-based immunotherapy after surgery or radiotherapy did not increase survival in patients with localized non-small-cell lung cancer (NSCLC), according to a meta-analysis published in the Cochrane Database of Systematic Reviews (online December 16 … |
